Trade Summary

1 month ago, Vacirca Jeff L, serving as Dir at Caris Life Sciences, Inc. (CAI), purchased 31,050 shares at $16.15 per share, for a total transaction value of $501,426.00. Following this transaction, Vacirca Jeff L now holds 49,671 shares of CAI.

This purchase represents a 167.00% increase in Vacirca Jeff L's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 11, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 12, 2026 at 8:22 AM ET, 1 day after the trade was made.

Caris Life Sciences, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.